Analysis of Anti-JCV antibody in Japanese patients with multiple sclerosis

被引：1
|
作者：
Aoyama, S. [1 ]
Mori, M. [2 ]
Uchida, T. [2 ]
Masuda, H. [2 ]
Ohtani, R. [2 ]
Sugimoto, K. [2 ]
Liu, J. [2 ]
Kuwabara, S. [2 ]
机构：
[1] Chiba Univ, Dept Neurol, Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan
[2] Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.682
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
654
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [41] Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
    Olivier Outteryck
    Jean-Claude Ongagna
    Alain Duhamel
    Hélène Zéphir
    Nicolas Collongues
    Arnaud Lacour
    Marie-Céline Fleury
    Anne-Sophie Berteloot
    Frédéric Blanc
    Marianne Giroux
    Patrick Vermersch
    Jérôme de Sèze
    Journal of Neurology, 2012, 259 : 2293 - 2298
  • [42] Longitudinal anti-JCV antibody titres increase with natalizumab treatment
    Raffel, J.
    Gafson, A.
    Malik, O.
    Nicholas, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 296 - 297
  • [43] Natalizumab efficacy is unaffected by baseline anti-JCV antibody status
    Hotermans, C.
    Subramanyam, M.
    Pace, A.
    Potts, J.
    JOURNAL OF NEUROLOGY, 2011, 258 : 255 - 255
  • [44] Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Duhamel, Alain
    Zephir, Helene
    Collongues, Nicolas
    Lacour, Arnaud
    Fleury, Marie-Celine
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Giroux, Marianne
    Vermersch, Patrick
    de Seze, Jorome
    JOURNAL OF NEUROLOGY, 2012, 259 (11) : 2293 - 2298
  • [45] Anti-JCV antibody sero-positivity and index value among Iranian patients with multiple sclerosis and its correlation with demographic data and previous therapies
    Koolaji, Sogol
    Allahabadi, Narges Sistany
    Ahmadi, Arash
    Sahraian, Mohammad Ali
    Eskandarieh, Sharareh
    Moghadasi, Abdolreza Naser
    Azimi, Amir Reza
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP8 - NP8
  • [46] Analysis of CD4+CD62L+peripheral blood T-cells in patients with multiple sclerosis - correlation with disease modifying treatment and anti-JCV antibody index
    Boziki, M. K.
    Papadopoulos, G.
    Lagoudaki, R.
    Polychroniadou, E.
    Bakirtzis, C.
    Grigoriadis, N.
    Karacostas, D.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 663 - 664
  • [47] Changes to anti-JCV antibody levels in a Swedish national MS cohort
    Warnke, Clemens
    Ramanujam, Ryan
    Plavina, Tatiana
    Bergstrom, Tomas
    Goelz, Susan
    Subramanyam, Meena
    Kockum, Ingrid
    Rahbar, Afsar
    Kieseier, Bernd C.
    Holmen, Carolina
    Olsson, Tomas
    Hillert, Jan
    Fogdell-Hahn, Anna
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11): : 1199 - 1205
  • [48] StratifyJCV Serum anti-JCV antibody assay for patients treated with natalizumab: quality control of sample analysis by Unilabs
    Svendsen, Sofie
    Skovgaard, Tine
    Carstensen, Kristine
    Drenth, Annemarie
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 978 - 979
  • [49] Tonsillectomy and Negative JCV Antibody Status in Multiple Sclerosis Patients
    Avila, Mirla
    Trevino, Sorleen
    Thakolwiboon, Smathorn
    Suady, Suhaireirene
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 158 - 158
  • [50] Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy
    Clausi, V.
    Martelli, F.
    Repice, A. M.
    Mechi, C.
    Magnani, E.
    Massacesi, L.
    Azzi, A.
    Giannecchini, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 467 - 467
12345